Integra Lifesciences Holdings Corp  

(Public, NASDAQ:IART)   Watch this stock  
Find more results for Stuart Gorelick
66.75
-0.77 (-1.14%)
May 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 66.35 - 68.88
52 week 44.11 - 69.03
Open 67.39
Vol / Avg. 132,384.00/215,530.00
Mkt cap 2.22B
P/E 55.08
Div/yield     -
EPS 1.21
Shares 32.93M
Beta 0.87
Inst. own 83%
Aug 3, 2015
Q2 2015 Integra LifeSciences Holdings Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 2, 2015
Integra LifeSciences Holdings Corp at Jefferies Global Healthcare Conference - 4:00PM EDT - Add to calendar
May 26, 2015
Integra LifeSciences Holdings Corp to Provide Historical Financials Adjusted for Discontinued Operations - Webcast
May 22, 2015
Integra LifeSciences Holdings Corp Annual Shareholders Meeting
May 20, 2015
Integra LifeSciences Holdings Corp Annual Shareholders Meeting (Estimated)
May 18, 2015
Integra LifeSciences Holdings Corp at UBS Global Healthcare Conference
May 14, 2015
Integra LifeSciences Holdings Corp at Bank of America Merrill Lynch Health Care Conference
May 6, 2015
Integra LifeSciences Holdings Corp at Deutsche Bank Health Care Conference
Apr 30, 2015
Q1 2015 Integra LifeSciences Holdings Corp Earnings Call - Webcast
Apr 30, 2015
Q1 2015 Integra LifeSciences Holdings Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 3.59% 3.66%
Operating margin 7.18% 7.06%
EBITD margin - 13.65%
Return on average assets 2.15% 2.45%
Return on average equity 4.83% 4.96%
Employees 3,400 -
CDP Score - -

Address

311 Enterprise Dr
PLAINSBORO, NJ 08536-3344
United States - Map
+1-609-2750500 (Phone)
+1-609-2755363 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Integra LifeSciences Holdings Corporation operates in medical technology. Integra offers solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. Integra was founded on a technology platform to repair and regenerate tissue with engineered collagen devices. The Company develops product lines for applications ranging from burn and deep tissue wounds to regeneration of Dura mater in the brain and repair of nerve and tendon. The Company manufactures and sells products in five business segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. The Company’s products include regenerative medicine implants, metal implants, instruments and equipment for orthopedic surgery, neurosurgery and general surgery. The U.S. Neurosurgery segment sells a line of products for neurosurgery and neuro critical care. The U.S. Instruments segment is a surgical instrument supplier in the United States.

Officers and directors

Stuart M. Essig Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Peter J. Arduini President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Glenn G Coleman Chief Financial Officer, Corporate Vice President
Age: 47
Bio & Compensation  - Reuters
Padma Thiruvengadam Chief Human Resources Officer, Corporate Vice President - Strategic Initiatives and Operational Excellence
Age: 50
Bio & Compensation  - Reuters
Kenneth Burhop Ph.D. Chief Scientific Officer, Corporate Vice President
Age: 61
Bio & Compensation  - Reuters
John Mooradian Corporate Vice President - Global Operations and Supply Chain
Age: 59
Bio & Compensation  - Reuters
Richard D. Gorelick Corporate Vice President, General Counsel, Administration, Secretary
Age: 54
Bio & Compensation  - Reuters
Mark A. Augusti Corporate Vice President, President - Orthopedics and Tissue Technologies
Age: 49
Bio & Compensation  - Reuters
Robert T. Davis Jr. Corporate Vice President, President - Specialty Surgical Solutions
Age: 56
Bio & Compensation  - Reuters
Deborah Leonetti Corporate Vice President - Global Services and Repair
Age: 59
Bio & Compensation  - Reuters